Latest Investment News

SGH Ltd has reaffirmed its FY25 guidance for high single-digit EBIT growth while targeting a net debt to EBITDA ratio of 2.0x by year-end, underpinned by disciplined capital allocation and operational improvements across its diversified industrial, energy, and media businesses.

James Hardie Industries plc reported a slight dip in FY25 sales and profits but met guidance, while announcing a transformative acquisition of The AZEK Company Inc to accelerate growth and synergies.

HomeCo Daily Needs REIT has announced a quarterly distribution of 2.125 cents per unit for the period ending March 31, 2025, reaffirming its commitment to delivering steady income to investors.

F.F.I. Holdings has corrected its earlier statement, confirming its $11 million entitlement offer at $3.50 per share is not underwritten. The offer aims to fund property development and debt reduction, with directors backing the raise.

Metro Mining’s latest update reveals a decline in Ore Reserves and Resources at Bauxite Hills Mine due to 2024 mining activity, with no new exploration additions. The company plans a significant capital expansion to boost production capacity.

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Whitefield Industrials Limited reported a 10% increase in core operating profit for the year ended March 2025, outperforming its benchmark with a 7.5% portfolio return and raising fully franked dividends to 10.5 cents per share.

Brisbane Broncos Limited revealed solid financial results and operational growth for 2024 at their 2025 Annual General Meeting, highlighting record membership and commercial gains alongside strategic investments.

Despite a tough 2024 NRL season for the men's team, Brisbane Broncos delivered record memberships, increased attendance, and a solid financial performance with a $5.7 million profit.

Atomo Diagnostics has released a Target Market Determination for a new capital raising involving options and shares, including a $1 million Share Purchase Plan and placement offer. The move targets eligible Australian shareholders and aims to bolster the company’s financial position amid a speculative investment environment.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

OFX Limited reported a resilient FY25 with steady revenue and strong cash flow, while advancing its New Client Platform and strategic market expansion despite economic headwinds.